カテゴリー： Market Monitor Global, 世界, 医療/バイオ

制酸薬の世界市場見通し2023年-2029年

◆英語タイトル：Antacids Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5659）◆商品コード：MMG23JU5659
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：78
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Antacids Market 調査レポートは次の情報を含め、グローバルにおけるの制酸薬市場規模と予測を収録しています。・世界の制酸薬市場：売上、2018年-2023年、2024年-2029年
・世界の制酸薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の制酸薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「非全身性制酸薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

制酸薬のグローバル主要企業は、AstraZeneca、 Takeda Pharmaceutical、 Pfizer、 Reckitt Benckiser、 Bayer、 Procter & Gamble、 GlaxoSmithKline、 Johnson & Johnson、 CONBA、 Xiuzheng Pharma、 Sanofi、 Bausch Health、 CR SANJIU、 Novartisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、制酸薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の制酸薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の制酸薬市場：タイプ別市場シェア、2022年
・非全身性制酸薬、全身性制酸薬

世界の制酸薬市場：用途別、2018年-2023年、2024年-2029年
世界の制酸薬市場：用途別市場シェア、2022年
・一般用医薬品、一般用医薬品

世界の制酸薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の制酸薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における制酸薬のグローバル売上、2018年-2023年
・主要企業における制酸薬のグローバル売上シェア、2022年
・主要企業における制酸薬のグローバル販売量、2018年-2023年
・主要企業における制酸薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
AstraZeneca、 Takeda Pharmaceutical、 Pfizer、 Reckitt Benckiser、 Bayer、 Procter & Gamble、 GlaxoSmithKline、 Johnson & Johnson、 CONBA、 Xiuzheng Pharma、 Sanofi、 Bausch Health、 CR SANJIU、 Novartis

*************************************************************

・調査・分析レポートの概要
制酸薬市場の定義
市場セグメント
世界の制酸薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の制酸薬市場規模
世界の制酸薬市場規模：2022年 VS 2029年
世界の制酸薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの制酸薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の制酸薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：非全身性制酸薬、全身性制酸薬
制酸薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：一般用医薬品、一般用医薬品
制酸薬の用途別グローバル売上・予測

・地域別市場分析
地域別制酸薬市場規模 2022年と2029年
地域別制酸薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
AstraZeneca、 Takeda Pharmaceutical、 Pfizer、 Reckitt Benckiser、 Bayer、 Procter & Gamble、 GlaxoSmithKline、 Johnson & Johnson、 CONBA、 Xiuzheng Pharma、 Sanofi、 Bausch Health、 CR SANJIU、 Novartis
...

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they’re also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
This report aims to provide a comprehensive presentation of the global market for Antacids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antacids. This report contains market size and forecasts of Antacids in global, including the following market information:
Global Antacids Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Antacids Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Antacids companies in 2022 (%)
The global Antacids market was valued at US$ 6399 million in 2022 and is projected to reach US$ 7955 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Antacid key players include CONBA, Bayer, Xiuzheng Pharma, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent.
In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antacids manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antacids Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antacids Market Segment Percentages, by Type, 2022 (%)
Non-Systemic Antacids
Systemic Antacids
Global Antacids Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antacids Market Segment Percentages, by Application, 2022 (%)
Rx Drug
OTC Drug
Global Antacids Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antacids Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antacids revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Antacids revenues share in global market, 2022 (%)
Key companies Antacids sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Antacids sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter & Gamble
GlaxoSmithKline
Johnson & Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antacids, market overview.
Chapter 2: Global Antacids market size in revenue and volume.
Chapter 3: Detailed analysis of Antacids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antacids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antacids capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Antacids Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antacids Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antacids Overall Market Size
2.1 Global Antacids Market Size: 2022 VS 2029
2.2 Global Antacids Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Antacids Sales: 2018-2029
3 Company Landscape
3.1 Top Antacids Players in Global Market
3.2 Top Global Antacids Companies Ranked by Revenue
3.3 Global Antacids Revenue by Companies
3.4 Global Antacids Sales by Companies
3.5 Global Antacids Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Antacids Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Antacids Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antacids Players in Global Market
3.8.1 List of Global Tier 1 Antacids Companies
3.8.2 List of Global Tier 2 and Tier 3 Antacids Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Antacids Market Size Markets, 2022 & 2029
4.1.2 Non-Systemic Antacids
4.1.3 Systemic Antacids
4.2 By Type – Global Antacids Revenue & Forecasts
4.2.1 By Type – Global Antacids Revenue, 2018-2023
4.2.2 By Type – Global Antacids Revenue, 2024-2029
4.2.3 By Type – Global Antacids Revenue Market Share, 2018-2029
4.3 By Type – Global Antacids Sales & Forecasts
4.3.1 By Type – Global Antacids Sales, 2018-2023
4.3.2 By Type – Global Antacids Sales, 2024-2029
4.3.3 By Type – Global Antacids Sales Market Share, 2018-2029
4.4 By Type – Global Antacids Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antacids Market Size, 2022 & 2029
5.1.2 Rx Drug
5.1.3 OTC Drug
5.2 By Application – Global Antacids Revenue & Forecasts
5.2.1 By Application – Global Antacids Revenue, 2018-2023
5.2.2 By Application – Global Antacids Revenue, 2024-2029
5.2.3 By Application – Global Antacids Revenue Market Share, 2018-2029
5.3 By Application – Global Antacids Sales & Forecasts
5.3.1 By Application – Global Antacids Sales, 2018-2023
5.3.2 By Application – Global Antacids Sales, 2024-2029
5.3.3 By Application – Global Antacids Sales Market Share, 2018-2029
5.4 By Application – Global Antacids Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Antacids Market Size, 2022 & 2029
6.2 By Region – Global Antacids Revenue & Forecasts
6.2.1 By Region – Global Antacids Revenue, 2018-2023
6.2.2 By Region – Global Antacids Revenue, 2024-2029
6.2.3 By Region – Global Antacids Revenue Market Share, 2018-2029
6.3 By Region – Global Antacids Sales & Forecasts
6.3.1 By Region – Global Antacids Sales, 2018-2023
6.3.2 By Region – Global Antacids Sales, 2024-2029
6.3.3 By Region – Global Antacids Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Antacids Revenue, 2018-2029
6.4.2 By Country – North America Antacids Sales, 2018-2029
6.4.3 US Antacids Market Size, 2018-2029
6.4.4 Canada Antacids Market Size, 2018-2029
6.4.5 Mexico Antacids Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Antacids Revenue, 2018-2029
6.5.2 By Country – Europe Antacids Sales, 2018-2029
6.5.3 Germany Antacids Market Size, 2018-2029
6.5.4 France Antacids Market Size, 2018-2029
6.5.5 U.K. Antacids Market Size, 2018-2029
6.5.6 Italy Antacids Market Size, 2018-2029
6.5.7 Russia Antacids Market Size, 2018-2029
6.5.8 Nordic Countries Antacids Market Size, 2018-2029
6.5.9 Benelux Antacids Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Antacids Revenue, 2018-2029
6.6.2 By Region – Asia Antacids Sales, 2018-2029
6.6.3 China Antacids Market Size, 2018-2029
6.6.4 Japan Antacids Market Size, 2018-2029
6.6.5 South Korea Antacids Market Size, 2018-2029
6.6.6 Southeast Asia Antacids Market Size, 2018-2029
6.6.7 India Antacids Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Antacids Revenue, 2018-2029
6.7.2 By Country – South America Antacids Sales, 2018-2029
6.7.3 Brazil Antacids Market Size, 2018-2029
6.7.4 Argentina Antacids Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Antacids Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Antacids Sales, 2018-2029
6.8.3 Turkey Antacids Market Size, 2018-2029
6.8.4 Israel Antacids Market Size, 2018-2029
6.8.5 Saudi Arabia Antacids Market Size, 2018-2029
6.8.6 UAE Antacids Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Antacids Major Product Offerings
7.1.4 AstraZeneca Antacids Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Takeda Pharmaceutical
7.2.1 Takeda Pharmaceutical Company Summary
7.2.2 Takeda Pharmaceutical Business Overview
7.2.3 Takeda Pharmaceutical Antacids Major Product Offerings
7.2.4 Takeda Pharmaceutical Antacids Sales and Revenue in Global (2018-2023)
7.2.5 Takeda Pharmaceutical Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Antacids Major Product Offerings
7.3.4 Pfizer Antacids Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Reckitt Benckiser
7.4.1 Reckitt Benckiser Company Summary
7.4.2 Reckitt Benckiser Business Overview
7.4.3 Reckitt Benckiser Antacids Major Product Offerings
7.4.4 Reckitt Benckiser Antacids Sales and Revenue in Global (2018-2023)
7.4.5 Reckitt Benckiser Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Antacids Major Product Offerings
7.5.4 Bayer Antacids Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Procter & Gamble
7.6.1 Procter & Gamble Company Summary
7.6.2 Procter & Gamble Business Overview
7.6.3 Procter & Gamble Antacids Major Product Offerings
7.6.4 Procter & Gamble Antacids Sales and Revenue in Global (2018-2023)
7.6.5 Procter & Gamble Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Antacids Major Product Offerings
7.7.4 GlaxoSmithKline Antacids Sales and Revenue in Global (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Antacids Major Product Offerings
7.8.4 Johnson & Johnson Antacids Sales and Revenue in Global (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 CONBA
7.9.1 CONBA Company Summary
7.9.2 CONBA Business Overview
7.9.3 CONBA Antacids Major Product Offerings
7.9.4 CONBA Antacids Sales and Revenue in Global (2018-2023)
7.9.5 CONBA Key News & Latest Developments
7.10 Xiuzheng Pharma
7.10.1 Xiuzheng Pharma Company Summary
7.10.2 Xiuzheng Pharma Business Overview
7.10.3 Xiuzheng Pharma Antacids Major Product Offerings
7.10.4 Xiuzheng Pharma Antacids Sales and Revenue in Global (2018-2023)
7.10.5 Xiuzheng Pharma Key News & Latest Developments
7.11 Sanofi
7.11.1 Sanofi Company Summary
7.11.2 Sanofi Antacids Business Overview
7.11.3 Sanofi Antacids Major Product Offerings
7.11.4 Sanofi Antacids Sales and Revenue in Global (2018-2023)
7.11.5 Sanofi Key News & Latest Developments
7.12 Bausch Health
7.12.1 Bausch Health Company Summary
7.12.2 Bausch Health Antacids Business Overview
7.12.3 Bausch Health Antacids Major Product Offerings
7.12.4 Bausch Health Antacids Sales and Revenue in Global (2018-2023)
7.12.5 Bausch Health Key News & Latest Developments
7.13 CR SANJIU
7.13.1 CR SANJIU Company Summary
7.13.2 CR SANJIU Antacids Business Overview
7.13.3 CR SANJIU Antacids Major Product Offerings
7.13.4 CR SANJIU Antacids Sales and Revenue in Global (2018-2023)
7.13.5 CR SANJIU Key News & Latest Developments
7.14 Novartis
7.14.1 Novartis Company Summary
7.14.2 Novartis Business Overview
7.14.3 Novartis Antacids Major Product Offerings
7.14.4 Novartis Antacids Sales and Revenue in Global (2018-2023)
7.14.5 Novartis Key News & Latest Developments
8 Global Antacids Production Capacity, Analysis
8.1 Global Antacids Production Capacity, 2018-2029
8.2 Antacids Production Capacity of Key Manufacturers in Global Market
8.3 Global Antacids Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antacids Supply Chain Analysis
10.1 Antacids Industry Value Chain
10.2 Antacids Upstream Market
10.3 Antacids Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antacids Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Antacids in Global Market
Table 2. Top Antacids Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Antacids Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Antacids Revenue Share by Companies, 2018-2023
Table 5. Global Antacids Sales by Companies, (K Units), 2018-2023
Table 6. Global Antacids Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Antacids Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Antacids Product Type
Table 9. List of Global Tier 1 Antacids Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antacids Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Antacids Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Antacids Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Antacids Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Antacids Sales (K Units), 2018-2023
Table 15. By Type - Global Antacids Sales (K Units), 2024-2029
Table 16. By Application – Global Antacids Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Antacids Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Antacids Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Antacids Sales (K Units), 2018-2023
Table 20. By Application - Global Antacids Sales (K Units), 2024-2029
Table 21. By Region – Global Antacids Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Antacids Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Antacids Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Antacids Sales (K Units), 2018-2023
Table 25. By Region - Global Antacids Sales (K Units), 2024-2029
Table 26. By Country - North America Antacids Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Antacids Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Antacids Sales, (K Units), 2018-2023
Table 29. By Country - North America Antacids Sales, (K Units), 2024-2029
Table 30. By Country - Europe Antacids Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Antacids Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Antacids Sales, (K Units), 2018-2023
Table 33. By Country - Europe Antacids Sales, (K Units), 2024-2029
Table 34. By Region - Asia Antacids Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Antacids Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Antacids Sales, (K Units), 2018-2023
Table 37. By Region - Asia Antacids Sales, (K Units), 2024-2029
Table 38. By Country - South America Antacids Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Antacids Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Antacids Sales, (K Units), 2018-2023
Table 41. By Country - South America Antacids Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Antacids Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Antacids Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Antacids Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Antacids Sales, (K Units), 2024-2029
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Antacids Product Offerings
Table 48. AstraZeneca Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Takeda Pharmaceutical Company Summary
Table 51. Takeda Pharmaceutical Antacids Product Offerings
Table 52. Takeda Pharmaceutical Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Takeda Pharmaceutical Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Antacids Product Offerings
Table 56. Pfizer Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Reckitt Benckiser Company Summary
Table 59. Reckitt Benckiser Antacids Product Offerings
Table 60. Reckitt Benckiser Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Reckitt Benckiser Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Antacids Product Offerings
Table 64. Bayer Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. Procter & Gamble Company Summary
Table 67. Procter & Gamble Antacids Product Offerings
Table 68. Procter & Gamble Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Procter & Gamble Key News & Latest Developments
Table 70. GlaxoSmithKline Company Summary
Table 71. GlaxoSmithKline Antacids Product Offerings
Table 72. GlaxoSmithKline Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. GlaxoSmithKline Key News & Latest Developments
Table 74. Johnson & Johnson Company Summary
Table 75. Johnson & Johnson Antacids Product Offerings
Table 76. Johnson & Johnson Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Johnson & Johnson Key News & Latest Developments
Table 78. CONBA Company Summary
Table 79. CONBA Antacids Product Offerings
Table 80. CONBA Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. CONBA Key News & Latest Developments
Table 82. Xiuzheng Pharma Company Summary
Table 83. Xiuzheng Pharma Antacids Product Offerings
Table 84. Xiuzheng Pharma Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Xiuzheng Pharma Key News & Latest Developments
Table 86. Sanofi Company Summary
Table 87. Sanofi Antacids Product Offerings
Table 88. Sanofi Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Sanofi Key News & Latest Developments
Table 90. Bausch Health Company Summary
Table 91. Bausch Health Antacids Product Offerings
Table 92. Bausch Health Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Bausch Health Key News & Latest Developments
Table 94. CR SANJIU Company Summary
Table 95. CR SANJIU Antacids Product Offerings
Table 96. CR SANJIU Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. CR SANJIU Key News & Latest Developments
Table 98. Novartis Company Summary
Table 99. Novartis Antacids Product Offerings
Table 100. Novartis Antacids Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Novartis Key News & Latest Developments
Table 102. Antacids Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Antacids Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Antacids Production by Region, 2018-2023 (K Units)
Table 105. Global Antacids Production by Region, 2024-2029 (K Units)
Table 106. Antacids Market Opportunities & Trends in Global Market
Table 107. Antacids Market Drivers in Global Market
Table 108. Antacids Market Restraints in Global Market
Table 109. Antacids Raw Materials
Table 110. Antacids Raw Materials Suppliers in Global Market
Table 111. Typical Antacids Downstream
Table 112. Antacids Downstream Clients in Global Market
Table 113. Antacids Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Antacids Segment by Type in 2022
Figure 2. Antacids Segment by Application in 2022
Figure 3. Global Antacids Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antacids Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Antacids Revenue, 2018-2029 (US$, Mn)
Figure 7. Antacids Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antacids Revenue in 2022
Figure 9. By Type - Global Antacids Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Antacids Revenue Market Share, 2018-2029
Figure 11. By Type - Global Antacids Sales Market Share, 2018-2029
Figure 12. By Type - Global Antacids Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Antacids Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Antacids Revenue Market Share, 2018-2029
Figure 15. By Application - Global Antacids Sales Market Share, 2018-2029
Figure 16. By Application - Global Antacids Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Antacids Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Antacids Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Antacids Revenue Market Share, 2018-2029
Figure 20. By Region - Global Antacids Sales Market Share, 2018-2029
Figure 21. By Country - North America Antacids Revenue Market Share, 2018-2029
Figure 22. By Country - North America Antacids Sales Market Share, 2018-2029
Figure 23. US Antacids Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Antacids Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Antacids Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Antacids Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Antacids Sales Market Share, 2018-2029
Figure 28. Germany Antacids Revenue, (US$, Mn), 2018-2029
Figure 29. France Antacids Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Antacids Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Antacids Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Antacids Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Antacids Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Antacids Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Antacids Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Antacids Sales Market Share, 2018-2029
Figure 37. China Antacids Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Antacids Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Antacids Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Antacids Revenue, (US$, Mn), 2018-2029
Figure 41. India Antacids Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Antacids Revenue Market Share, 2018-2029
Figure 43. By Country - South America Antacids Sales Market Share, 2018-2029
Figure 44. Brazil Antacids Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Antacids Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Antacids Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Antacids Sales Market Share, 2018-2029
Figure 48. Turkey Antacids Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Antacids Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Antacids Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Antacids Revenue, (US$, Mn), 2018-2029
Figure 52. Global Antacids Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Antacids by Region, 2022 VS 2029
Figure 54. Antacids Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 制酸薬の世界市場見通し2023年-2029年(Antacids Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 制酸薬の世界市場2023年～2030年：剤型別、流通チャネル別、地域別
  • 制酸剤の世界市場2022：非全身性制酸剤、全身性制酸剤
  • 制酸剤の世界市場2023-2030：市場規模、シェア、動向分析
  • 速溶性フィルムの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆